Research

Journal Article

Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia

April 2, 2023

Featured Experts: Neeraj Sood, PhD, Seth Seabury, PhD, Victoria Shier, PhD, Geoffrey Joyce, PhD

Journal Article

Formulary Restrictions and Stroke Risk in Patients With Atrial Fibrillation

August 4, 2022

Featured Experts: Seth Seabury, PhD, Dana Goldman, PhD, Geoffrey Joyce, PhD

Journal Article

Benzodiazepine Use and the Risk of Dementia

July 20, 2022

Featured Experts: Geoffrey Joyce, PhD, Johanna Thunell, PhD, Bryan Tysinger, PhD, Julie Zissimopoulos, PhD

Journal Article

Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, Drug Manufacturers, and the Federal Government

July 14, 2022

Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD

Issue Brief

Race and Ethnic Differences in the Association Between Alzheimer’s Disease Risk and Use of Prescription Medications for Chronic Conditions

June 28, 2022

Featured Experts: Julie Zissimopoulos, PhD, Geoffrey Joyce, PhD, Johanna Thunell, PhD

Comment Letter

Comments to the Federal Trade Commission on Pharmacy Benefit Managers

May 25, 2022

Featured Experts: Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Karen Mulligan, PhD, Neeraj Sood, PhD, Erin Trish, PhD, Karen Van Nuys, PhD

Perspective

I Wrongly Expected COVID to Fade Last Summer — Here’s What to Expect This Time

May 24, 2022

Featured Experts: Geoffrey Joyce, PhD

Journal Article

Pharmacy Switching in Response to Preferred Pharmacy Networks in Medicare Part D

March 17, 2022

Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD

Journal Article

Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members

July 7, 2021

Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD, Geoffrey Joyce, PhD

Perspective

COVID-19 Is on the Run — Expect the Pandemic to Be Under Control by Memorial Day

February 19, 2021

Featured Experts: Geoffrey Joyce, PhD

News

Monthly Cost Sharing Doubles Throughout the Year for Some Medicare Insulin Users

February 9, 2021

Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD

Journal Article

Variation in Generic Dispensing Rates in Medicare Part D

November 13, 2020

Featured Experts: Geoffrey Joyce, PhD

Journal Article

Pharmaceutical Treatment for Alzheimer’s Disease and Related Dementias: Utilization and Disparities

July 21, 2020

Featured Experts: Geoffrey Joyce, PhD, Emmanuel Drabo, PhD, Julie Zissimopoulos, PhD

News

Coronavirus Treatments, Not Just Vaccines, Will Save Lives and Generate Value

July 9, 2020

Featured Experts: Karen Mulligan, PhD, Karen Van Nuys, PhD, Desi Peneva, MS, Geoffrey Joyce, PhD

Perspective

5 COVID-19 Myths

July 9, 2020

Featured Experts: Geoffrey Joyce, PhD

White Paper

The Value of Treatment for COVID-19

July 8, 2020

Featured Experts: Karen Mulligan, PhD, Karen Van Nuys, PhD, Desi Peneva, MS, Geoffrey Joyce, PhD

Perspective

Are We Overreacting to the Coronavirus? Let’s Do the Math.

April 19, 2020

Featured Experts: Geoffrey Joyce, PhD

News

Drug Cost-Sharing Based on Net Price Benefits Medicare Part D Patients

March 17, 2020

Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD

White Paper

How Would Sharing Rebates at the Point-Of-Sale Affect Beneficiary Cost-Sharing in Medicare Part D?

March 17, 2020

Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD

Journal Article

Association of Combination Statin and Antihypertensive Therapy With Reduced Alzheimer’s Disease and Related Dementia Risk

March 11, 2020

Featured Experts: Geoffrey Joyce, PhD, Julie Zissimopoulos, PhD